Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A first-generation copper peptide that breaks down when combined with Vitamin C requires different handling than a second-generation version designed for better stability
If an underlying condition is responsible (liver disease, kidney disease, myeloproliferative disorder, or cancer), treating the underlying condition is the priority
FOXO4-DRI Based on 1 publication(s) in Google Scholar FOXO4-DRI is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53
Additionally, bronchopulmonary dysplasia, in which bombesins have been implicated, may increase the risk for development of COPD later in life [213]
These studies help determine the maximum safe dose and identify any possible side effects
US$ 23.27
US$ 21.33
US$ 24.16
US$ 21.65
